Transdermal therapeutic system containing pergolide

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6461636
SERIAL NO

09673069

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a transdermal therapeutic system (TTS) for the transcutaneous administration of pergolide over several days and to a method for its manufacture without using solvents. The TTS contains a matrix mass, containing pergolide and taking the form of a layer, which contains a (meth)acrylate copolymer containing ammonio groups or a mixture of a (meth)acrylate copolymer containing amino groups and a (meth)acrylate polymer containing carboxyl groups, 10-50% by weight propylene glycol and up to 5% by weight pergolide.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SCHWARZ PHARMA AG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arth, Christoph Dusseldorf, DE 13 225
Kollmeyer-Seeger, Andreas Langenfeld, DE 2 59
Rimpler, Stephan Hilden, DE 4 120
Wolff, Hans-Michael Monheim, DE 36 617

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation